Rorze

Rorze EBIT per Employee

The EBIT per Employee of Rorze (6323.T) as of Oct 21, 2026 is 7.13 M JPY. In the previous year, EBIT per Employee was 7.33 M JPY — a change of -2.72% (lower).

EBIT per Employee

7.13 MJPY

YoY

-2.72%

Last updated:

EBIT per Employee of Rorze is 2026 7.13 M JPY. EBIT per Employee of Rorze was 2025 7.33 M JPY. It decreases by -2.72% lower compared to the previous year.

The Rorze EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
1.33 M JPY
Jan 1, 2020
1.77 M JPY
Jan 1, 2021
2.13 M JPY
Jan 1, 2022
3.62 M JPY
Jan 1, 2023
6.04 M JPY
Jan 1, 2024
5.52 M JPY
Jan 1, 2025
7.33 M JPY
Jan 1, 2026
7.13 M JPY
The Rorze EBIT per Employee history
YEAREBIT per EmployeeYoY
7.13 MJPY-2.72%
7.33 MJPY+32.67%
5.52 MJPY-8.63%
6.04 MJPY+67.10%
3.62 MJPY+69.74%
2.13 MJPY+20.28%
1.77 MJPY+33.22%
1.33 MJPY+37.21%
968,980.33JPY-7.34%
1.05 MJPY+55.59%
672,147.30JPY+275.72%
178,897.99JPY-32.67%
265,720.72JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rorze Stock analysis

What does Rorze do? Rorze Corp. generates revenue through the sale of automation systems for semiconductor and FPD production. The Semiconductor and FPD-related equipment segment offers products such as EFEM, wafer transporters for atmosphere and vacuum, wafer sorters, stockers for N2 purge, transport units, large glass substrate transporters, glass cutting machines, and stepping motor drivers and controllers. These products are sold to semiconductor and LCD industry clients. The Life Science segment provides cell culture devices including incubators, targeting the drug discovery industry and related fields. Both segments focus on delivering specialized equipment to industrial clients requiring precision manufacturing solutions in their respective markets. The company's primary customers in the semiconductor and FPD sectors are manufacturers of semiconductors and flat panel displays. These clients purchase automation systems to enhance production efficiency and maintain cleanroom standards. In the Life Science segment, pharmaceutical and biotechnology firms buy cell culture devices for research and development purposes. Rorze Corp. serves these segments with tailored equipment designed for high-precision industrial applications. Rorze Corp.'s business model revolves around developing and selling specialized machinery for two key industrial markets. The Semiconductor and FPD-related equipment segment drives the majority of sales with its range of dust-free transport solutions. The Life Science segment complements this by offering cell culture devices that support drug discovery processes. Both segments rely on direct sales to industrial clients seeking advanced automation for their manufacturing and research operations. Rorze is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rorze stock

EBIT per Employee of Rorze is 7.13 M JPY in 2026.

EBIT per Employee of Rorze changed from 7.33 M JPY to 7.13 M JPY, representing a -2.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Rorze since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Rorze historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Rorze

All Key Metrics — Rorze